GS-Nitroxide (JP4-039)-Mediated Radioprotection of Human Fanconi Anemia Cell Lines

Two Strategies for the Development of Mitochondrion-Targeted Small Molecule Radiation Damage Mitigators

(2011) Jean-Claude M. Rwigema et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol

(2010) Q.-S. Zhang et al.   BLOOD

Haematopoeitic cell transplantation for Fanconi anaemia - when and how?

(2010) Margaret L. MacMillan et al.   BRITISH JOURNAL OF HAEMATOLOGY

Deficiencies in the Fanconi Anemia DNA Damage Response Pathway Increase Sensitivity to HPV-Associated Head and Neck Cancer

(2010) J. W. Park et al.   CANCER RESEARCH

A Phase I Study of Concurrent Chemotherapy (Paclitaxel and Carboplatin) and Thoracic Radiotherapy with Swallowed Manganese Superoxide Dismutase Plasmid Liposome Protection in Patients with Locally Advanced Stage III Non-Small-Cell Lung Cancer

(2010) Ahmad A. Tarhini et al.   HUMAN GENE THERAPY

Cytokinesis failure occurs in Fanconi anemia pathway–deficient murine and human bone marrow hematopoietic cells

(2010) Patrizia Vinciguerra et al.   JOURNAL OF CLINICAL INVESTIGATION

Hematopoietic Stem Cell Defects in Mice with Deficiency of Fancd2 or Usp1

(2010) Kalindi Parmar et al.   STEM CELLS

Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation

(2008) Caroline Masserot et al.   CANCER

Tempol Protects against Oxidative Damage and Delays Epithelial Tumor Onset in Fanconi Anemia Mice

(2008) Q.-S. Zhang et al.   CANCER RESEARCH

The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly

(2008) Kanchan D. Mirchandani et al.   DNA REPAIR

The Chemistry of Fluorescent Bodipy Dyes: Versatility Unsurpassed

(2007) Gilles Ulrich et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION